Starpharma
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4-6 Southampton Cres, Abbotsford, Victor...Phone Number
+61385322700Website
www.starpharma.comRevenue
$9.9 MillionStock Symbol
SPLIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Starpharma
Starpharma Holdings Limited is a biotechnology company specializing in dendrimer products for pharmaceutical and life-science applications. Their innovative DEP drug delivery platform targets the effective delivery of various drugs, particularly in oncology. With a commitment to improving patient health outcomes, Starpharma collaborates strategically with industry leaders. Their products address significant health challenges, including womens health and infectious diseases, leveraging proprietary technology to meet clinical needs.Explore more
Starpharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Starpharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Starpharma has new funding data
Website visits: Recent activity has been detected on your website
Check if Starpharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Starpharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Starpharma
Product Launch: Get notified when Starpharma launches new products
Check out if Starpharma is spiking on competitors!
Click to see if Starpharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Starpharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Starpharma
Find 2 more new buyers
Compare Similar Companies to Starpharma
Compare insights from companies similar to Starpharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Starpharma
$9.9M
11-50
Public
$23M
1996
AB
Andrew BondFinancial Controller & Company Assistant & Secretary
Company Profile Activity
Activity Insights
Starpharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Starpharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Starpharma.
Starpharma financials insights
Gather financial insights about Starpharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Stock/Share Issuance
$23M
Starpharma Tech Stack
A closer look at the technologies used by Starpharma
Most Recent Scoops
Person-Based
Clinical Operations, Finance, Investor Relations
Funding
Starpharma has secured $22.98 million in Stock/Share Issuance funding. Investors were not disclosed.
Funding
Partnership
Partnership, Product Development, Product Management, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals
Left Company
Executive Move
Left Company
Executive Move
Starpharma News & Media
Loss-Making Starpharma Holdings Limited (ASX:SPL) Expected To Breakeven In The Medium-Term
With the business potentially at an important milestone, we thought we'd take a closer look at Starpharma Holdings...Starpharma Announces a Collaboration and License Agreement with Genentech
MELBOURNE, Australia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Starpharma (ASX: SPL, US OTC: SPHRY), an innovative Australian biotechnology company, today announced the signing of a collaboration and license agreement with Genentech, a member of the Roche Group, to develop potential cancer therapies that leverage Starpharma’s proprietary DEP® drug delivery technology.Starpharma Secures $3.7 Million R&D Tax Incentive to Boost Biotechnology Advancements
Starpharma Holdings Limited ( ($AU:SPL) ) has provided an update. Starpharma Holdings Limited has received a $3.7 million R&D Tax Incentive refund for the 2025 fina...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Starpharma
Sign Up For FreeTo access detailed company insights
Starpharma Holdings Limited is a biotechnology company specializing in dendrimer products for pharmaceutical and life-science applications. Their innovative DEP drug delivery platform targets the effective delivery of various drugs, particularly in oncology. With a commitment to improving patient health outcomes, Starpharma collaborates strategical... Read More
